Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1958 2
1959 2
1961 1
1967 1
1968 1
1977 1
1978 2
1979 1
1984 3
1985 2
1986 1
1990 1
1996 1
2004 1
2006 2
2007 3
2008 6
2009 3
2010 5
2011 5
2012 4
2013 8
2014 5
2015 6
2016 8
2017 5
2018 4
2019 6
2020 9
2021 9
2022 7
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline.
Rathmell WK, Rumble RB, Van Veldhuizen PJ, Al-Ahmadie H, Emamekhoo H, Hauke RJ, Louie AV, Milowsky MI, Molina AM, Rose TL, Siva S, Zaorsky NG, Zhang T, Qamar R, Kungel TM, Lewis B, Singer EA. Rathmell WK, et al. Among authors: molina am. J Clin Oncol. 2022 Sep 1;40(25):2957-2995. doi: 10.1200/JCO.22.00868. Epub 2022 Jun 21. J Clin Oncol. 2022. PMID: 35728020
Smart Targeting To Improve Cancer Therapeutics.
Morales-Cruz M, Delgado Y, Castillo B, Figueroa CM, Molina AM, Torres A, Milián M, Griebenow K. Morales-Cruz M, et al. Among authors: molina am. Drug Des Devel Ther. 2019 Oct 30;13:3753-3772. doi: 10.2147/DDDT.S219489. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31802849 Free PMC article. Review.
Rare T-cell lymphomas.
Molina AM, Horwitz SM. Molina AM, et al. Cancer Treat Res. 2008;142:331-47. doi: 10.1007/978-0-387-73744-7_14. Cancer Treat Res. 2008. PMID: 18283793 Review.
mTOR inhibitors in advanced renal cell carcinoma.
Voss MH, Molina AM, Motzer RJ. Voss MH, et al. Among authors: molina am. Hematol Oncol Clin North Am. 2011 Aug;25(4):835-52. doi: 10.1016/j.hoc.2011.04.008. Hematol Oncol Clin North Am. 2011. PMID: 21763970 Free PMC article. Review.
Recommendations for the Management of Rare Kidney Cancers.
Giles RH, Choueiri TK, Heng DY, Albiges L, Hsieh JJ, Linehan WM, Pal S, Maskens D, Paseman B, Jonasch E, Malouf G, Molina AM, Pickering L, Shuch B, Srinivas S, Srinivasan R, Tannir NM, Bex A. Giles RH, et al. Among authors: molina am. Eur Urol. 2017 Dec;72(6):974-983. doi: 10.1016/j.eururo.2017.06.040. Epub 2017 Jul 16. Eur Urol. 2017. PMID: 28720391 Review.
Targeting renal cell carcinoma.
Motzer RJ, Molina AM. Motzer RJ, et al. Among authors: molina am. J Clin Oncol. 2009 Jul 10;27(20):3274-6. doi: 10.1200/JCO.2009.21.8461. Epub 2009 May 18. J Clin Oncol. 2009. PMID: 19451422 No abstract available.
Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, open-label, phase IIIb/IV CheckMate 920 trial.
George DJ, Spigel DR, Gordan LN, Kochuparambil ST, Molina AM, Yorio J, Rezazadeh Kalebasty A, McKean H, Tchekmedyian N, Tykodi SS, Zhang J, Askelson M, Johansen JL, Hutson TE. George DJ, et al. Among authors: molina am. BMJ Open. 2022 Sep 14;12(9):e058396. doi: 10.1136/bmjopen-2021-058396. BMJ Open. 2022. PMID: 36104138 Free PMC article. Clinical Trial.
103 results